These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26573545)

  • 1. Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy.
    Pedersen HL; Horvei KD; Thiyagarajan D; Seredkina N; Rekvig OP
    Semin Nephrol; 2015 Sep; 35(5):427-38. PubMed ID: 26573545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential.
    Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C
    Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Anti-DNA Antibodies in the Development of Lupus Nephritis: A Complementary, or Alternative, Viewpoint?
    Goilav B; Putterman C
    Semin Nephrol; 2015 Sep; 35(5):439-43. PubMed ID: 26573546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future Perspectives on Pathogenesis of Lupus Nephritis: Facts, Problems, and Potential Causal Therapy Modalities.
    Rekvig OP; Thiyagarajan D; Pedersen HL; Horvei KD; Seredkina N
    Am J Pathol; 2016 Nov; 186(11):2772-2782. PubMed ID: 27664472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lupus, DNase and defective disposal of cellular debris.
    Walport MJ
    Nat Genet; 2000 Jun; 25(2):135-6. PubMed ID: 10835621
    [No Abstract]   [Full Text] [Related]  

  • 6. Circulating chromatin-anti-chromatin antibody complexes bind with high affinity to dermo-epidermal structures in murine and human lupus nephritis.
    Fismen S; Hedberg A; Fenton KA; Jacobsen S; Krarup E; Kamper AL; Rekvig OP; Mortensen ES
    Lupus; 2009 Jun; 18(7):597-607. PubMed ID: 19433459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nephritogenic potential of anti-DNA antibodies against necrotic nucleosomes.
    Mortensen ES; Rekvig OP
    J Am Soc Nephrol; 2009 Apr; 20(4):696-704. PubMed ID: 19329762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephritogenic antibodies bind in glomeruli through interaction with exposed chromatin fragments and not with renal cross-reactive antigens.
    Mjelle JE; Rekvig OP; Van Der Vlag J; Fenton KA
    Autoimmunity; 2011 Aug; 44(5):373-83. PubMed ID: 21244336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis.
    Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP
    Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclease deficiencies promote end-stage lupus nephritis but not nephritogenic autoimmunity in (NZB × NZW) F1 mice.
    Fismen S; Mortensen ES; Rekvig OP
    Immunol Cell Biol; 2011 Jan; 89(1):90-9. PubMed ID: 20548325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible pathogenic role of cationic anti-DNA autoantibodies in the development of nephritis in patients with systemic lupus erythematosus.
    Suzuki N; Harada T; Mizushima Y; Sakane T
    J Immunol; 1993 Jul; 151(2):1128-36. PubMed ID: 8335894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin exerts a dual effect on murine lupus nephritis by enhancing enzymatic chromatin degradation and preventing chromatin binding in glomerular membranes.
    Hedberg A; Fismen S; Fenton KA; Fenton C; Osterud B; Mortensen ES; Rekvig OP
    Arthritis Rheum; 2011 Apr; 63(4):1065-75. PubMed ID: 21190297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular targets for autoantibodies in lupus nephritis--an apoptotic origin.
    Zykova SN; Seredkina NE; Rekvig OP
    Ann N Y Acad Sci; 2007 Jun; 1108():1-10. PubMed ID: 17893965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New immunosuppresor strategies in the treatment of murine lupus nephritis.
    Alperovich G; Rama I; Lloberas N; Franquesa M; Poveda R; Gomà M; Herrero-Fresneda I; Cruzado JM; Bolaños N; Carrera M; Grinyó JM; Torras J
    Lupus; 2007; 16(1):18-24. PubMed ID: 17283580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromatin as a target antigen in human and murine lupus nephritis.
    Hedberg A; Mortensen ES; Rekvig OP
    Arthritis Res Ther; 2011 Apr; 13(2):214. PubMed ID: 21542875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lupus nephritis: enigmas, conflicting models and an emerging concept.
    Seredkina N; Van Der Vlag J; Berden J; Mortensen E; Rekvig OP
    Mol Med; 2013 Jul; 19(1):161-9. PubMed ID: 23752208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exposure of chromatin and not high affinity for dsDNA determines the nephritogenic impact of anti-dsDNA antibodies in (NZBxNZW)F1 mice.
    Mjelle JE; Kalaaji M; Rekvig OP
    Autoimmunity; 2009 Feb; 42(2):104-11. PubMed ID: 19005880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dsDNA, Anti-dsDNA Antibody, and Lupus Nephritis: What We Agree on, What Must Be Done, and What the Best Strategy Forward Could Be.
    Rekvig OP
    Front Immunol; 2019; 10():1104. PubMed ID: 31156647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deposition of chromatin-IgG complexes in skin of nephritic MRL-lpr/lpr mice is associated with increased local matrix metalloprotease activities.
    Hedberg A; Fismen S; Fenton KA; Mortensen ES; Rekvig OP
    Exp Dermatol; 2010 Aug; 19(8):e265-74. PubMed ID: 20500770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-DNA antibody subpopulations and lupus nephritis.
    Rekvig OP; Kalaaji M; Nossent H
    Autoimmun Rev; 2004 Feb; 3(2):1-6. PubMed ID: 15003181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.